Related Experiment Video
Updated: Jul 4, 2026

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
A DNA vaccine for the prevention of Ebola virus infection
Markalain Dery1, Daniel G Bausch
1Tulane University Health Sciences Center, Department of Medicine, Infectious Diseases Section, 1430 Tulane Ave SL-87, New Orleans, LA 70112-2699, USA. madery@tulane.edu
Abstract:
The NIH and Vical Inc are developing an intramuscular needle-free DNA vaccine containing plasmids encoding the envelope glycoprotein of Ebola virus (EBOV) from the Sudan and Zaire strains, and the nucleoprotein of EBOV Zaire strain. A phase I clinical trial demonstrated a good safety profile, with most adverse events limited to the site of injection and largely attributable to the delivery.
Related Concept Videos
Cross-reactivity
Yellow Fever
Respiratory Syncytial Virus Disease
Poliomyelitis

